Test Cookie policy: All websites across the EU are now required to ask your permission to place cookies on your machine, and you can refuse to give it.

We have limited Spanish content available. View Spanish content.

The Deal

Healthcare to Remain a Hotbed for PE Dealmaking: Bain & Company

Healthcare to Remain a Hotbed for PE Dealmaking: Bain & Company

Besides long-term trends including an aging population and the increasing prevalence of chronic disease, Bain & Company cited two other factors that are fueling investors' interest in North American healthcare assets.

  • abril 22, 2019
  • min read

The Deal

Healthcare to Remain a Hotbed for PE Dealmaking: Bain & Company

A high level of dealflow from private equity firms in the healthcare sector is likely to continue at a rapid pace in 2019, according to consulting firm Bain & Company.

"We are quite bullish on the continued high level of activity in 2019 in healthcare PE," said Nirad Jain, a partner with Bain & Company who co-heads the global healthcare private equity and corporate M&A practices, in an interview on the heels of the release of Bain's Global Healthcare Private Equity and Corporate M&A Report 2019, which released Wednesday, April 17.

Last year, disclosed transaction values for healthcare PE deals totaled $63.1 billion globally, marking the highest level since 2006 and an increase from $42.6 billion in 2017, according to the report. 2018 saw eight transactions valued north of $2 billion, compared with four in 2017.